Reveles Clinical Services President and CEO R'Kes Starling [Photo: Reveles]
Reveles' new DCT management platform broadens access to clinical trials by enabling patients to participate—without leaving their homes.
The technology includes enabling eConsent from existing and potential patients; online video and audio between patients and healthcare providers; direct data collection including real-time data, compliance, and status view featuring eSource, eDiaries, devices, wearables, questionnaires, and surveys; and telemedicine tools.